Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease

NCT03149809 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT03149809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03149809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
Lead sponsor
VA Office of Research and Development
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2018
Completion date
September 8, 2023
Enrollment
77 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, parkinson disease